Mitigating Inspection Findings Related to Clinical Trial Protocol Design Gaps – pharmaceutical drug regulatory affairs Mitigating Inspection Findings Related to Clinical Trial Protocol Design Gaps Clinical trial protocols are foundational documents that govern the conduct of clinical studies and ensure regulatory compliance across various jurisdictions, including the US, EU, and India. The importance of addressing clinical trial protocol design gaps cannot be overstated, as deficiencies in these protocols can lead to significant inspection findings with serious implications for pharmaceutical drug regulatory affairs. This step-by-step guide aims to provide pharmaceutical professionals with insights and practical steps to mitigate inspection findings related…